Literature DB >> 15660289

Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases.

Glaucio R W Castro1, Simone Appenzeller, João Francisco Marques-Neto, Manoel B Bértolo, Adil M Samara, Ibsen Coimbra.   

Abstract

Camurati-Engelmann disease is a rare bone disorder characterized by cortical thickening of the diaphysis of tubular bones, with sparing of the epiphysis. It has variable degrees of penetrance and expression, but may be very disabling for the affected individuals who manifest the painful symptoms. The authors report on two women with typical presentation of severe Camurati-Engelmann disease whose treatment with bisphosphonates failed to add any improvement beyond that elicited by corticosteroids alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660289     DOI: 10.1007/s10067-004-1056-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Pamidronate in the treatment of progressive diaphyseal dysplasia (Camurati-Engelmann disease)

Authors:  G Chérié-Lignière; G Santalena; A Parafioriti
Journal:  Clin Exp Rheumatol       Date:  1999 Mar-Apr       Impact factor: 4.473

Review 2.  Sclerosing bone dysplasias--a target-site approach.

Authors:  A Greenspan
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

3.  Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family.

Authors:  M V Hernández; P Peris; N Guañabens; L Alvarez; A Monegal; F Pons; A Ponce; J Muñoz-Gómez
Journal:  Calcif Tissue Int       Date:  1997-07       Impact factor: 4.333

4.  Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature.

Authors:  R S Sparkes; C B Graham
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

5.  Progressive diaphyseal dysplasia (Engelmann disease(: scintigraphic-radiographic-clinical correlations.

Authors:  B Kumar; W A Murphy; M P Whyte
Journal:  Radiology       Date:  1981-07       Impact factor: 11.105

6.  Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease.

Authors:  A Kinoshita; T Saito; H Tomita; Y Makita; K Yoshida; M Ghadami; K Yamada; S Kondo; S Ikegawa; G Nishimura; Y Fukushima; T Nakagomi; H Saito; T Sugimoto; M Kamegaya; K Hisa; J C Murray; N Taniguchi; N Niikawa; K Yoshiura
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease).

Authors:  T Inaoka; N Shuke; J Sato; Y Ishikawa; K Takahashi; T Aburano; Y Makita
Journal:  Clin Nucl Med       Date:  2001-08       Impact factor: 7.794

8.  Engelmann's disease and the effect of corticosteroids. A case report.

Authors:  A M Minford; G J Hardy; W I Forsythe; J M Fitton; V L Rowe
Journal:  J Bone Joint Surg Br       Date:  1981

9.  Camurati-Engelmann disease: contribution of bone scintigraphy to genetic counseling.

Authors:  C Clybouw; S Desmyttere; M Bonduelle; A Piepsz
Journal:  Genet Couns       Date:  1994

10.  Camurati-Engelmann disease. Review of radioclinical features.

Authors:  F M Vanhoenacker; K Janssens; W Van Hul; R Gershoni-Baruch; R Brik; A M De Schepper
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

View more
  13 in total

1.  Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.

Authors:  Jonas Bondestam; Mervi K Mäyränpää; Shiro Ikegawa; Eino Marttinen; Heikki Kröger; Outi Mäkitie
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

2.  A significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati-Engelmann disease.

Authors:  Kousuke Iba; Junichi Takada; Hotaka Kamasaki; Takashi Oda; Naoko Hatakeyama; Takuro Wada; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

3.  Pain improvement in Camurati-Engelmann disease after anti-TNFα therapy.

Authors:  Sónia Moreira; Bernardo Cunha; Nelson Pedro Jesus; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2017-11-28

4.  Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.

Authors:  S Herrera; R Soriano; X Nogués; R Güerri-Fernandez; D Grinberg; N García-Giralt; N Martínez-Gil; S Castejón; A González-Lizarán; S Balcells; A Diez-Perez
Journal:  Osteoporos Int       Date:  2017-08-25       Impact factor: 4.507

5.  Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease.

Authors:  Giampiero I Baroncelli; Elena Ferretti; Cecilia M Pini; Benedetta Toschi; Rita Consolini; Silvano Bertelloni
Journal:  Mol Syndromol       Date:  2017-09-09

Review 6.  Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.

Authors:  Lijia Cui; Qian Li; Wenmin Guan; Wei Yu; Xiang Li; Weibo Xia; Yan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

Review 7.  Significant Improvement After Surgery for a Symptomatic Osteoblastoma in a Patient with Camurati-Engelmann Disease: Case Report and Literature Review.

Authors:  Hirotaka Yonezawa; Katsuhiro Hayashi; Norio Yamamoto; Akihiko Takeuchi; Kaoru Tada; Shinji Miwa; Kentaro Igarashi; Hiroaki Kimura; Yu Aoki; Sei Morinaga; Yoshihiro Araki; Yohei Asano; Keisuke Sakurakichi; Hiroko Ikeda; Takayuki Nojima; Hiroyuki Tsuchiya
Journal:  Calcif Tissue Int       Date:  2021-02-08       Impact factor: 4.333

8.  Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

Authors:  Michael P Whyte; William G Totty; Deborah V Novack; Xiafang Zhang; Deborah Wenkert; Steven Mumm
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

9.  Orthopedic Manifestations of Type I Camurati-Engelmann Disease.

Authors:  Alisher J Yuldashev; Chang Ho Shin; Yong Sung Kim; Woo Young Jang; Moon Seok Park; Jong Hee Chae; Won Joon Yoo; In Ho Choi; Ok Hwa Kim; Tae-Joon Cho
Journal:  Clin Orthop Surg       Date:  2017-02-13

10.  Visual and otologic manifestation of Camurati-Engelmann's disease: a case report.

Authors:  Tariq Alam; Muhammad Khurram; Hidayatullah Hamidi; Asif Alam Khan
Journal:  Radiol Case Rep       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.